对神经退行性疾病的拟议机制的审查
Benjamin M Kelser1, Eric M Teichner2, Robert C Subtirelu3
1School of Medicine, Case Western Reserve University, Cleveland, OH, United States.
Frontiers in aging neuroscience
|October 23, 2024
概括
神经退行性疾病是复杂的,目前正在研究两个主要理论:突触传播和选择性脆弱性. 了解这些机制是开发有效治疗阿尔茨海默氏症和帕金森症等疾病的关键.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 病理学 病理学 病理学
背景情况:
- 数以百万计的人受到神经退行性疾病的影响,如阿尔茨海默氏症,帕金森症和ALS.
- 涉及的关键蛋白质包括tau,α-synuclein和TDP-43.
- 目前的研究讨论了两个主要假设:突触传播和选择性脆弱性.
研究的目的:
- 探索神经退行症中的突触传播和选择性脆弱性假设.
- 突出特定蛋白质在疾病机制中的作用.
- 讨论新的神经成像技术的影响.
主要方法:
- 审查关于神经退行性疾病假设的现有文献.
- 对致病性蛋白质 (tau,α-synuclein,TDP-43) 的作用进行分析.
- 考虑PET/MRI混合成像技术的进展.
主要成果:
- 突触传播假设假设蛋白质的细胞间传播,如α-synuclein和β-amyloid.
- 选择性脆弱性假说表明,由于代谢压力,神经元内在的敏感性是固有的.
- 神经成像为这些复杂的机制提供了新的见解.
结论:
- 突触传播和选择性脆弱性假设都得到证据的支持.
- 每种假设对神经退行症的确切贡献需要进一步调查.
- 持续的研究对于开发神经退行性疾病的有效治疗方法至关重要.
相关概念视频
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...


